Thinking about the future is a defining aspect of the human condition, with science and technology increasingly used to shape our vision of things to come. But how can the non-stop and ever faster techno-scientific innovation that characterizes our times be put to use to implement these visions? This is the main theme of The Future of Science international conference’s 13th edition – entitled “The Lives to Come” – that will be held at the Fondazione Giorgio Cini (on the island of San Giorgio Maggiore) in Venice, Italy, on September 21-22. The aim of the conference is to examine the importance of scientific development as a mean of improving the quality of our lives, and to outline a new role for science in third millennium society.
Kedrion Biopharma is proud to support this initiative once again, and to take part in the conference. A panel presentation on “Biopharmaceuticals: Present and Future Perspectives” by Kedrion’s Chief R&D Officer Mike Fournel is scheduled on day two: the latest successes in pharmaceutical and biopharmaceutical innovation will be discussed using specific examples, always taking into consideration the ethical dilemmas encountered along the way, and the regulatory and governmental challenges faced when introducing new therapies.
